Oppenheimer Asset Management Inc. Sells 2,330 Shares of Steris PLC (STE)

Oppenheimer Asset Management Inc. cut its stake in shares of Steris PLC (NYSE:STE) by 6.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 31,262 shares of the medical equipment provider’s stock after selling 2,330 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Steris were worth $3,340,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in STE. Millennium Management LLC grew its stake in shares of Steris by 109.4% during the 2nd quarter. Millennium Management LLC now owns 6,522 shares of the medical equipment provider’s stock valued at $685,000 after acquiring an additional 75,587 shares during the period. Jane Street Group LLC bought a new position in shares of Steris during the 2nd quarter valued at approximately $782,000. Advisors Asset Management Inc. grew its stake in shares of Steris by 67.9% during the 2nd quarter. Advisors Asset Management Inc. now owns 11,937 shares of the medical equipment provider’s stock valued at $1,254,000 after acquiring an additional 4,826 shares during the period. Northern Trust Corp grew its stake in shares of Steris by 0.7% during the 2nd quarter. Northern Trust Corp now owns 643,608 shares of the medical equipment provider’s stock valued at $67,585,000 after acquiring an additional 4,623 shares during the period. Finally, United Services Automobile Association grew its stake in shares of Steris by 8.1% during the 2nd quarter. United Services Automobile Association now owns 16,039 shares of the medical equipment provider’s stock valued at $1,684,000 after acquiring an additional 1,206 shares during the period. Institutional investors own 87.70% of the company’s stock.

In other Steris news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $120.50, for a total value of $1,205,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP John Adam Zangerle sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, January 25th. The stock was sold at an average price of $115.00, for a total value of $345,000.00. Following the completion of the transaction, the vice president now owns 33,796 shares of the company’s stock, valued at $3,886,540. The disclosure for this sale can be found here. Insiders sold a total of 49,250 shares of company stock valued at $5,853,520 over the last 90 days. 2.38% of the stock is currently owned by corporate insiders.

STE stock opened at $114.73 on Friday. Steris PLC has a 1-year low of $82.88 and a 1-year high of $121.67. The company has a quick ratio of 2.01, a current ratio of 2.63 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $9.69 billion, a price-to-earnings ratio of 27.65 and a beta of 1.04.

Steris (NYSE:STE) last posted its quarterly earnings results on Tuesday, November 6th. The medical equipment provider reported $1.10 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.08 by $0.02. Steris had a return on equity of 12.15% and a net margin of 11.72%. The business had revenue of $679.00 million during the quarter, compared to the consensus estimate of $659.14 million. During the same period in the prior year, the company posted $0.94 EPS. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. On average, sell-side analysts expect that Steris PLC will post 4.78 EPS for the current fiscal year.

A number of brokerages recently issued reports on STE. Zacks Investment Research upgraded Steris from a “sell” rating to a “hold” rating in a research note on Tuesday, October 9th. KeyCorp boosted their price objective on Steris from $120.00 to $132.00 and gave the company an “overweight” rating in a research note on Tuesday, November 13th. Finally, Sidoti boosted their price objective on Steris from $155.00 to $157.00 and gave the company a “buy” rating in a research note on Thursday, December 6th. Six research analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and a consensus price target of $128.83.

TRADEMARK VIOLATION WARNING: “Oppenheimer Asset Management Inc. Sells 2,330 Shares of Steris PLC (STE)” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.com-unik.info/2019/02/03/oppenheimer-asset-management-inc-sells-2330-shares-of-steris-plc-ste.html.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Recommended Story: Bid-Ask Spread

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit